Commonwealth Equity Services »

Oncolytics Biotech shares owned by Commonwealth Equity Services

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Commonwealth Equity Services from 13F filings

Historical chart of Commonwealth Equity Services investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Commonwealth Equity Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $75k 56k 1.35

More positions owned by Commonwealth Equity Services

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus 1000 Grw Etf (IWF)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Value Etf (VTV)
Vanguard Specialized Funds Div App Etf (VIG)

View all positions for Commonwealth Equity Services

Top funds holding Oncolytics Biotech

International Assets Investment Management
Millennium Management
Citadel Advisors
Commonwealth Equity Services
Royal Bank of Canada
Long Focus Capital Management
Bank Of Montreal
Ausdal Financial Partners
Brave Asset Management
Two Sigma Securities
C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors
Banque Cantonale Vaudoise
Headinvest
Jpmorgan Chase & Co
Kingsview Wealth Management

View all funds holding Oncolytics Biotech